4//SEC Filing
KEANE WILLIAM P 4
Accession 0001209191-12-002077
CIK 0001009356other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:21 PM ET
Size
8.3 KB
Accession
0001209191-12-002077
Insider Transaction Report
Form 4
KEANE WILLIAM P
Director
Transactions
- Tax Payment
Common Stock
2012-01-03$47.85/sh−1,717$82,158→ 39,042 total
Holdings
- 15,000
Option to Buy Common Stock
Exercise: $17.63Exp: 2015-06-09→ Common Stock (15,000 underlying) - 22,500
Option to Buy Common Stock
Exercise: $18.87Exp: 2014-06-17→ Common Stock (22,500 underlying) - 30,000
Option to Buy Common Stock
Exercise: $15.25Exp: 2014-01-14→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]Represents shares forfeited to the company in connection with the satisfaction of tax liabilities incurred upon the vesting of restricted stock.
- [F2]Options are 100% vested.
Documents
Issuer
SALIX PHARMACEUTICALS LTD
CIK 0001009356
Entity typeother
Related Parties
1- filerCIK 0001204286
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 4:21 PM ET
- Size
- 8.3 KB